Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Imatinib and MMF in Children with Steroid-Refractory Sclerotic/Fibrotic cGVHD
NCT01898377Phase 2Terminated
- Sponsor
- Seoul National University Hospital
- Start
- Aug 2013
- Primary completion
- Feb 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of imatinib in chronic graft-versus-host disease (cGVHD), sponsored by Seoul National University Hospital. Started Aug 2013; status: terminated.
02
Drugs
03
Conditions
chronic graft-versus-host disease (cGVHD)
Beyond the preview
Go deeper on NCT01898377.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01898377.